Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 231 of 5804
-
Could a single dose of MDMA supercharge PTSD therapy?
Symptom relief Recruiting nowThe goal of this clinical trial is to investigate the efficacy of 3,4-methylenedioxy-methamphetamine hydrochloride (MDMA) combined with Massed Prolonged Exposure (PE) therapy for the treatment of posttraumatic stress disorder (PTSD) in adult participants diagnosed with PTSD. This…
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New hope for frail hodgkin patients: immunotherapy-chemo combo shows promise
Disease control Recruiting nowThis phase II trial tests how well pembrolizumab in addition to chemotherapy (gemcitabine, brentuximab vedotin, and dacarbazine) works in treating frail patients with newly diagnosed Hodgkin lymphoma who aren't candidates for standard anthracycline-based treatment. Immunotherapy …
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New brain zaps aim to lift depression when meds fail
Symptom relief Not yet recruitingThe purpose of this study is to confirm the efficacy of two recently introduced repetitive transcranial magnetic stimulation (rTMS) interventions - accelerated intermittent theta-burst stimulation (aiTBS) and individualized neuronavigation - in treatment-resistant depression (TRD…
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New combo could cut hormone therapy time for prostate cancer patients
Disease control Not yet recruitingThis research is being done to find out if the study drug, 177Lu-PSMA-617, given before and during standard of care External Beam Radiation Therapy (EBRT) treatment, with a shorter course of Androgen Deprivation Therapy (ADT) (6 months) is (1) safe and effective compared to stand…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New eye injection could mean fewer doctor visits for wet AMD patients
Disease control Not yet recruitingThe goal of this study is to evaluate whether AIV007 provides benefits to patients with neovascular age-related macular degeneration in improving vision and that it has an acceptable safety profile. Participants will receive either a periocular injection of AIV007 or intravitrea…
Phase: PHASE2 • Sponsor: AiViva BioPharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Could a common steroid save lives in severe lung failure?
Disease control Not yet recruitingAcute respiratory distress syndrome (ARDS) is a major cause of acute hypoxemic respiratory failure in critically ill patients and is associated with substantial mortality. Current management is largely supportive, and no pharmacologic therapy has been shown consistently to reduce…
Phase: PHASE3 • Sponsor: Southeast University, China • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can remote monitoring and community support tame postpartum high blood pressure?
Disease control Not yet recruitingThe goal of this randomized clinical trial is to evaluate the effectiveness of a collaborative care intervention, consisting of remote blood pressure monitoring and support from community health workers, in improving blood pressure control and reducing postpartum complications am…
Phase: NA • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New migraine pill aims to stop pain in 2 hours – major trial underway
Symptom relief Recruiting nowThis is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with placebo, in the acute treatment of migraine.
Phase: PHASE3 • Sponsor: Kallyope Inc. • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New hope for AML patients: gentler drug combo could replace harsh chemo
Disease control Not yet recruitingThis prospective, multicenter, randomized, open-label, non-inferiority clinical study aims to compare the efficacy and safety of VA regimen (venetoclax combined with azacitidine) versus conventional "3+7" chemotherapy regimen in adult patients aged 18 to 65 years with newly diagn…
Phase: PHASE2 • Sponsor: Shen yang • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Promising drug cocktail aims to save voice boxes in throat cancer patients
Disease control Recruiting nowThis clinical trial aims to evaluate the efficacy and safety of Becotatug Vedotin (EGFR-ADC) in combination with Pucotenlimab(Anti-PD-1 Monoclonal Antibody) as neoadjuvant therapy for patients with Resectable Locally Advanced Hypopharyngeal Squamous Cell Carcinoma. The primary o…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a gentle electric field heal the heart? new study tests Pulsed-Field ablation for persistent AF
Disease control Not yet recruitingAtrial fibrillation (AF) is associated with both electrical and structural remodeling of the left atrium. While successful catheter ablation has been shown to reverse some aspects of atrial remodeling, the impact of pulsed-field ablation (PFA) - a non-thermal ablation technology …
Phase: NA • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Virtual reality tested as a calming tool during chemo
Symptom relief Not yet recruitingThis randomized controlled trial aims to evaluate the effectiveness of virtual reality-guided imagery in reducing pain, anxiety, and fatigue among female breast cancer patients undergoing adjuvant chemotherapy. Participants will be randomly assigned to either an intervention grou…
Phase: NA • Sponsor: Thoalfokar Mohammed Al-Obaidi • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New PET scan could predict who benefits from targeted lung cancer therapy
Disease control Not yet recruitingThe primary objective is to evaluate the correlation between ⁶⁸Ga-MY6349 PET/CT-derived metrics reflecting tumoral TROP2 expression activity (including SUVmax, SUVmean, MTV, TLG, etc.) and progression-free survival (PFS) assessed per RECIST v1.1. This study plans to enroll 100 EG…
Phase: PHASE2 • Sponsor: Zhou Chengzhi • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
AI could help doctors pick better diabetes drugs
Disease control Not yet recruitingThis study tests whether an artificial intelligence (AI) tool can help doctors choose better diabetes medicines for their patients. Type 2 diabetes is very common, but there are far more patients than diabetes specialists, so many patients are treated by doctors who are not diabe…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a diabetes drug boost pregnancy success in women with PCOS?
Disease control Not yet recruitingThe goal of this clinical trial is to examine whether GLP1-RA and healthy lifestyle education in women with PCOS and obesity prior to fertility treatment improves live birth rate and other reproductive, maternal and perinatal outcomes compared to metformin plus healthy lifestyle …
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Radar reflectors could sharpen breast cancer surgery and cut repeat operations
Disease control Not yet recruitingThe purpose of the study is to evaluate how precise the SAVI Scout MD is and how easy it is for surgeons to use during surgery. The SAVI Scout MD system uses tiny radar reflectors instead of wires, can be placed days or weeks before surgery, helps surgeons find the cancer more pr…
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Simple arm cuff before angioplasty may boost heart attack recovery
Disease control Recruiting nowThis prospective, randomized study was designed to evaluate whether the noninvasive artificial venous stasis / RE-START procedure, administered prior to primary percutaneous coronary intervention, increases the frequency of spontaneous coronary reperfusion in the infarct-related …
Sponsor: Firat University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug aims to calm severe eczema without steroids
Disease control Recruiting nowThis is an interventional, randomized, parallel group, treatment, Phase 3, double blind study to assess the effect of Rezpegaldesleukin in participants 12 years of age or older with moderate to severe atopic dermatitis, as compared to placebo. The estimated participant overall d…
Phase: PHASE3 • Sponsor: Nektar Therapeutics • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Tailored HIIT may boost fitness in stubborn heart failure
Disease control Not yet recruitingCardiovascular-Kidney-Metabolic (CKM) Syndrome is a continuous clinical disease spectrum integrating cardiovascular, renal, and metabolic disorders. Heart failure with preserved ejection fraction (HFpEF) is considered Stage 4 of CKM syndrome, characterized primarily by impairment…
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Bispecific antibody shows promise for Hard-to-Treat lymphoma in Real-World study
Disease control Not yet recruitingB-cell non-Hodgkin lymphoma (B-NHL) is the most common type of lymphoma. Although first-line R-CHOP can cure a proportion of patients, approximately 30%-40% relapse or become refractory (R/R). CD20xCD3 bispecific antibodies, represented by glofitamab, have shown significant effic…
Sponsor: Yanyan Liu • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC